NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Flow Neuroscience

Flow Neuroscience

Private
MalmöHealthcare & Life Scienceshttps://www.flowneuroscience.us/

Last Round

Series A

Aug 10, 2021

Total Funding Raised

$10.1M

Company Overview

Flow Neuroscience is a medical technology company that develops a non-invasive, at-home brain stimulation headset and companion mobile application for the treatment of major depressive disorder.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, Patient Engagement

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

transcranial direct current stimulationtDCSbrain stimulationbrain zapdepression treatmentat-home medical devicedigital behavioral therapynon-pharmacological treatmentmental health techFDA-cleared devicedigital health platformneurotechdirect-to-consumer healthchatbot therapistmood tracking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Flow Neuroscience Comparables

Compare Flow Neuroscience with similar companies based on industry and business-model similarity.

Flow Neuroscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mave Health
88%
Neurolief
84%
Sooma
84%

Flow Neuroscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 10, 2021
VC RoundJul 23, 2019
SeedJan 25, 2018
AcceleratorSep 15, 2017

Key People

Founding team and executive leadership

Daniel Månsson

Chief Clinical Officer And Founder

Founding Team

Erik M. Rehn

CTO Co-founder

Founding Team

Erin Sivyer Lee

Chief Executive Officer

Executive Team

James Buss

Chief Financial Officer

Executive Team

Flow Neuroscience Investors

Notable investors and investment history

Flow Neuroscience investors
InvestorRounds
Khosla VenturesVC Round, Series A, Seed
Zühlke VenturesSeries A
Redstone VCSeries A
Schox Patent GroupSeries A
SOSVSeed
HAXAccelerator, Series A, Seed

Flow Neuroscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Flow Neuroscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Flow Neuroscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersMalmö
Employee Range40
Year Founded2016
Last FundingAug 10, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.